Forecasts data is unavailable for this security.
Consensus recommendation
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 0 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Calidi Biotherapeutics Inc have a median target of 6.25, with a high estimate of 10.00 and a low estimate of 2.50. The median estimate represents a 473.39% increase from the last price of 1.09.
High | 817.4% | 10.00 |
Med | 473.4% | 6.25 |
Low | 129.4% | 2.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 15, 2024.
Average growth rate | -51.51% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
More ▼